Search research articles
Contact Us
Filters
Showing results (201-210 of 230) with videos related to
Page
of 23
Sort By:
BMC Cancer
|
October 3, 2022
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, et al.
Scientific Reports
|
July 2, 2024
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, et al.
Thoracic Cancer
|
October 26, 2021
Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study
Miki Hoshi, Nobuaki Kobayashi, Katsushi Tanaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 19, 2014
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells
Keisuke Watanabe, Seitaro Terakura, Anton C Martens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Plos One
|
August 1, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse
Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi, et al.
The Journal of Infectious Diseases
|
November 10, 2023
Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis
Yoichi Tagami, Nobuyuki Horita, Megumi Kaneko, et al.
Blood Advances
|
April 14, 2023
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Keisuke Watanabe, Angela M Gomez, Shunichiro Kuramitsu, et al.
Therapeutic Advances in Medical Oncology
|
September 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis
Hiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita, et al.
International Journal of Hematology
|
October 4, 2016
A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia
Kotaro Miyao, Masashi Sawa, Mio Kurata, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 230) with videos related to
Sort By:
Page
of 23
BMC Cancer
|
October 3, 2022
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, et al.
Scientific Reports
|
July 2, 2024
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, et al.
Thoracic Cancer
|
October 26, 2021
Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study
Miki Hoshi, Nobuaki Kobayashi, Katsushi Tanaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 19, 2014
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells
Keisuke Watanabe, Seitaro Terakura, Anton C Martens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Plos One
|
August 1, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse
Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi, et al.
The Journal of Infectious Diseases
|
November 10, 2023
Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis
Yoichi Tagami, Nobuyuki Horita, Megumi Kaneko, et al.
Blood Advances
|
April 14, 2023
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Keisuke Watanabe, Angela M Gomez, Shunichiro Kuramitsu, et al.
Therapeutic Advances in Medical Oncology
|
September 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis
Hiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita, et al.
International Journal of Hematology
|
October 4, 2016
A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia
Kotaro Miyao, Masashi Sawa, Mio Kurata, et al.
Page
of 23